In English | En español
Questions About Cancer? 1-800-4-CANCER

NCI Drug Dictionary

  

pan FGFR inhibitor ARQ 087 
An orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with potential antineoplastic activity. FGFR inhibitor ARQ 087 binds to and potently inhibits the activity of FGFR subtypes 1, 2 and 3. This may result in the inhibition of FGFR-mediated signal transduction pathways, tumor cell proliferation, tumor angiogenesis and tumor cell death in FGFR-overexpressing tumor cells. FGFR, a receptor tyrosine kinase, is upregulated in many tumor cell types and plays a key role in tumor cellular proliferation, differentiation, angiogenesis and survival. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Code name:ARQ 087